+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | 1332D4-RBD KP3.1.1 Complex | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | SARS-CoV-2 / KP3.1.1 / Antibody / Complex / VIRAL PROTEIN / VIRAL PROTEIN-IMMUNE SYSTEM complex | |||||||||
| Biological species | Homo sapiens (human) / ![]() | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.56 Å | |||||||||
Authors | Kizziah JL / Walter MR | |||||||||
| Funding support | United States, 1 items
| |||||||||
Citation | Journal: iScience / Year: 2026Title: Emergence of neutralizing RBD antibodies following Omicron infection with limited activity against ancestral SARS-CoV-2. Authors: Michael S Piepenbrink / Yao Ma / Simran Panjwani / Alexandra R Blake / Allison M Bell / James L Kizziah / Sara H Mahmoud / Gregory C Ippolito / Nathan B Erdmann / Paul A Goepfert / Luis ...Authors: Michael S Piepenbrink / Yao Ma / Simran Panjwani / Alexandra R Blake / Allison M Bell / James L Kizziah / Sara H Mahmoud / Gregory C Ippolito / Nathan B Erdmann / Paul A Goepfert / Luis Martinez-Sobrido / James J Kobie / Mark R Walter / ![]() Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution reduces the efficacy of prophylactic vaccines and monoclonal antibody (mAb) therapies. To evaluate potency and breadth, receptor ...Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution reduces the efficacy of prophylactic vaccines and monoclonal antibody (mAb) therapies. To evaluate potency and breadth, receptor binding domain (RBD)-targeting neutralizing mAbs were identified from patient B cells using an Omicron KP3.1.1 Spike (S) protein bait. MAbs exhibiting the greatest neutralization potency (1332D4 and 1332E5) and binding breadth (1324A10 and 1316C10) were evaluated in greater detail. Cryo-electron microscopy (Cryo-EM) studies revealed 1332D4 and 1332E5 target RBD residue segments 439-446 and 498-506 of KP3.1.1 S, respectively. 1332E5 is a knob-targeting class-1/4 mAb that exhibits pan-Omicron specificity but does not bind or neutralize ancestral Wuhan-1. Further analysis suggests mAbs generically defined as class 1/4 mAbs may be separated into two classes. Class 1/4 mAbs, like 1332E5, and class 4/1 mAbs that make extensive interactions with the class-4 epitope and limited contacts with the class-1 knob. Despite these differences, the specificity of both mAb classes can be altered by mutations in knob. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_75696.map.gz | 777.7 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-75696-v30.xml emd-75696.xml | 22.2 KB 22.2 KB | Display Display | EMDB header |
| Images | emd_75696.png | 36.7 KB | ||
| Filedesc metadata | emd-75696.cif.gz | 7.4 KB | ||
| Others | emd_75696_half_map_1.map.gz emd_75696_half_map_2.map.gz | 764.6 MB 764.6 MB | ||
| Archive directory | https://data.pdbj.org/pub/emdb/structures/EMD-75696 ftp://data.pdbj.org/pub/emdb/structures/EMD-75696 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 11hmMC ![]() 11hoC ![]() 11isC ![]() 11itC M: atomic model generated by this map C: citing same article ( |
|---|
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_75696.map.gz / Format: CCP4 / Size: 824 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.717 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #2
| File | emd_75696_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #1
| File | emd_75696_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : 1332D4-SARS-CoV-2 KP3.1.1 RBD Complex
| Entire | Name: 1332D4-SARS-CoV-2 KP3.1.1 RBD Complex |
|---|---|
| Components |
|
-Supramolecule #1: 1332D4-SARS-CoV-2 KP3.1.1 RBD Complex
| Supramolecule | Name: 1332D4-SARS-CoV-2 KP3.1.1 RBD Complex / type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#3 |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: SARS-CoV-2 KP3.1.1
| Macromolecule | Name: SARS-CoV-2 KP3.1.1 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Molecular weight | Theoretical: 139.754953 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MGWSCIILFL VATATGVHSA YTNFTRGVYY PDKVFRSSVL HLTQDLFLPF FSNVTWFHAI SGTNGTKRFD NPVLPFNDGV YFASTEKSN IIRGWIFGTT LDSKTQSLLI VNNATNVFIK VCEFQFCNDP FLDVYHKNNK SWMESESGVY SSANNCTFEY V SQPFLMDL ...String: MGWSCIILFL VATATGVHSA YTNFTRGVYY PDKVFRSSVL HLTQDLFLPF FSNVTWFHAI SGTNGTKRFD NPVLPFNDGV YFASTEKSN IIRGWIFGTT LDSKTQSLLI VNNATNVFIK VCEFQFCNDP FLDVYHKNNK SWMESESGVY SSANNCTFEY V SQPFLMDL EGKQGNFKNL REFVFKNIDG YFKIYSKHTP IIGRDFPQGF SALEPLVDLP IGINITRFQT LLALNRSYLT PG DSSSGWT AGAADYYVGY LQPRTFLLKY NENGTITDAV DCALDPLSET KCTLKSFTVE KGIYQTSNFR VQPTESIVRF PNV TNLCPF HEVFNATRFA SVYAWNRTRI SNCVADYSVL YNFAPFFAFK CYGVSPTKLN DLCFTNVYAD SFVIKGNEVS QIAP GQTGN IADYNYKLPD DFTGCVIAWN SNKLDSKHSG NYDYWYRSLR KSKLKPFERD ISTEIYQAGN KPCKGKGPNC YFPLE SYGF RPTYGVGHQP YRVVVLSFEL LHAPATVCGP KKSTNLVKNK CVNFNFNGLT GTGVLTKSNK KFLPFQQFGR DIVDTT DAV RDPQTLEILD ITPCSFGGVS VITPGTNTSN QVAVLYQGVN CTEVSVAIHA DQLTPTWRVY STGSNVFQTR AGCLIGA EY VNNSYECDIP IGAGICASYQ TQTKSRGSAG SVASQSIIAY TMSLGAENSV AYSNNSIAIP TNFTISVTTE ILPVSMTK T SVDCTMYICG DSTECSNLLL QYGSFCTQLK RALTGIAVEQ DKNTQEVFAQ VKQIYKTPPI KYFGGFNFSQ ILPDPSKPS KRSPIEDLLF NKVTLADAGF IKQYGDCLGD IAARDLICAQ KFNGLTVLPP LLTDEMIAQY TSALLAGTIT SGWTFGAGPA LQIPFPMQM AYRFNGIGVT QNVLYENQKL IANQFNSAIG KIQDSLFSTP SALGKLQDVV NHNAQALNTL VKQLSSKFGA I SSVLNDIL SRLDPPEAEV QIDRLITGRL QSLQTYVTQQ LIRAAEIRAS ANLAATKMSE CVLGQSKRVD FCGKGYHLMS FP QSAPHGV VFLHVTYVPA QEKNFTTAPA ICHDGKAHFP REGVFVSNGT HWFLTQRNFY EPQIITTDNT FVSGNCDVVI GIV NNTVYD PLQLELDSFK EELDKYFKNH TSPDVDLGDI SGINASVVNI QKEIDRLNEV AKNLNESLID LQELGKYEQY IASS GYIPE APRDGQAYVR KDGEWVLLST FLEGTKHHHH HHHHGGSGGL NDIFEAQKIE WHE |
-Macromolecule #2: 1332D4 Heavy Chain
| Macromolecule | Name: 1332D4 Heavy Chain / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 25.708041 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MGWSCIILFL VATATGVHSQ VQLVQSGAEV KKPGESLRIS CKTSGYIFTN FWIGWARQMP GKGLEWMGII YPDDSDTRYS PSFQGQVTI SADKSISTAY LQWSTLKASD TAMYYCVRPD GVNDWFGVDP WGQGTLVTVS SASTKGPSVF PLAPCSKSTS G GTAALGCL ...String: MGWSCIILFL VATATGVHSQ VQLVQSGAEV KKPGESLRIS CKTSGYIFTN FWIGWARQMP GKGLEWMGII YPDDSDTRYS PSFQGQVTI SADKSISTAY LQWSTLKASD TAMYYCVRPD GVNDWFGVDP WGQGTLVTVS SASTKGPSVF PLAPCSKSTS G GTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EP |
-Macromolecule #3: 1332D4 Light Chain
| Macromolecule | Name: 1332D4 Light Chain / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 25.559523 KDa |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MGWSCIILFL VATATGVHSE TTLTQSPATL SVSPGERATL SCRASQSVTT NLAWYQQKPG RAPRLLIYGA STRATGIPAR FSGSGSGTE FTLTISSLQS EDFALYYCQQ YNHWPPYTFG QGTKLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF Y PREAKVQW ...String: MGWSCIILFL VATATGVHSE TTLTQSPATL SVSPGERATL SCRASQSVTT NLAWYQQKPG RAPRLLIYGA STRATGIPAR FSGSGSGTE FTLTISSLQS EDFALYYCQQ YNHWPPYTFG QGTKLEIKRT VAAPSVFIFP PSDEQLKSGT ASVVCLLNNF Y PREAKVQW KVDNALQSGN SQESVTEQDS KDSTYSLSST LTLSKADYEK HKVYACEVTH QGLSSPVTKS FNRGEC |
-Macromolecule #4: 2-acetamido-2-deoxy-beta-D-glucopyranose
| Macromolecule | Name: 2-acetamido-2-deoxy-beta-D-glucopyranose / type: ligand / ID: 4 / Number of copies: 2 / Formula: NAG |
|---|---|
| Molecular weight | Theoretical: 221.208 Da |
| Chemical component information | ![]() ChemComp-NAG: |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 0.9 mg/mL |
|---|---|
| Buffer | pH: 7.2 / Details: 1x Phosphate Buffered Saline |
| Grid | Model: C-flat-2/2 / Material: COPPER / Mesh: 400 / Support film - Material: CARBON / Support film - topology: HOLEY ARRAY / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 25 sec. / Pretreatment - Atmosphere: AIR / Pretreatment - Pressure: 0.039 kPa |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV |
-
Electron microscopy
| Microscope | TFS GLACIOS |
|---|---|
| Temperature | Min: 91.0 K |
| Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Average electron dose: 50.0 e/Å2 |
| Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm |
| Sample stage | Specimen holder model: OTHER / Cooling holder cryogen: NITROGEN |
Movie
Controller
About Yorodumi




Keywords
Homo sapiens (human)
Authors
United States, 1 items
Citation






Z (Sec.)
Y (Row.)
X (Col.)





































Processing
FIELD EMISSION GUN
